Accessed 4 August 2012
Infectious diseases: Innovation can still be a matter of life or death
Financial Times | 31 July 2012
By Andrew Jack
If necessity is the mother of invention, self-interest is the father. The influenza pandemic of 2009 – which first caught the public eye in Mexico – triggered a surge in research, investment and health preparations in the west to tackle the latest manifestation of an ancient scourge. Richer governments invested billions of dollars in purchasing vaccines and drugs, in the process stimulating fresh activity by companies into new technologies in a field long neglected by lack of interest and money.